Sacral neuromodulation for faecal incontinence following obstetric sphincter injury - outcome of percutaneous nerve evaluation

2017 ◽  
Vol 19 (3) ◽  
pp. 274-282 ◽  
Author(s):  
M. B. Rydningen ◽  
T. Dehli ◽  
T. Wilsgaard ◽  
R. O. Lindsetmo ◽  
M. Kumle ◽  
...  
Keyword(s):  
Faecal Incontinence ◽  
Sacral Neuromodulation ◽  
Sphincter Injury ◽  
Percutaneous Nerve Evaluation

Sacral neuromodulation in patients with congenital faecal incontinence. Special issues and review of the literature

2018 ◽  
Vol 22 (2) ◽  
pp. 89-95 ◽  
Author(s):  
L. Lagares-Tena ◽  
L. Millán-Paredes ◽  
L. Lázaro-García ◽  
A. Navarro-Luna ◽  
S. Delgado-Rivilla ◽  
...  
Keyword(s):  
Faecal Incontinence ◽  
Sacral Neuromodulation ◽  
Review Of The Literature

Sacral neuromodulation for faecal incontinence – 10 years' experience at a Scottish tertiary centre

The Surgeon ◽  
2018 ◽  
Vol 16 (4) ◽  
pp. 207-213 ◽  
Author(s):  
Hoey Koh ◽  
Stephen McSorley ◽  
Sarah Hunt ◽  
Martha Quinn ◽  
Graham MacKay ◽  
...  
Keyword(s):  
Faecal Incontinence ◽  
Sacral Neuromodulation ◽  
Tertiary Centre

Anal acoustic reflectometry predicts the outcome of percutaneous nerve evaluation for faecal incontinence

2014 ◽  
Vol 101 (10) ◽  
pp. 1310-1316 ◽  
Author(s):  
B. R. Hornung ◽  
G. L. Carlson ◽  
P. J. Mitchell ◽  
N. Klarskov ◽  
G. Lose ◽  
...  
Keyword(s):  
Faecal Incontinence ◽  
Percutaneous Nerve Evaluation

Sacral neuromodulation in a patient with faecal incontinence and unknown sacral partial agenesis

2017 ◽  
Vol 19 (5) ◽  
pp. 502-504 ◽  
Author(s):  
L. Lagares-Tena ◽  
C. Corbella-Sala ◽  
A. Navarro-Luna ◽  
A. Muñoz-Duyos
Keyword(s):  
Faecal Incontinence ◽  
Sacral Neuromodulation

scholarly journals The effect of the number of active electrode poles during tined lead placement on long‐term efficacy of sacral neuromodulation in patients with faecal incontinence

2020 ◽  
Vol 22 (12) ◽  
pp. 2140-2145
Author(s):  
R. Assmann ◽  
S. O. Breukink ◽  
S. A. P. Caubergh ◽  
L. P. S. Stassen ◽  
S. M. J. Kuijk ◽  
...  
Keyword(s):  
Faecal Incontinence ◽  
Sacral Neuromodulation ◽  
Active Electrode ◽  
Term Efficacy ◽  
Lead Placement ◽  
Tined Lead

scholarly journals Early versus late treatment of voiding dysfunction with pelvic neuromodulation

2012 ◽  
Vol 1 (2) ◽  
Author(s):  
Magdy M. Hassouna ◽  
Mohamed S. Elkelini
Keyword(s):  
Retrospective Study ◽  
Voiding Dysfunction ◽  
Sacral Neuromodulation ◽  
Early Group ◽  
Established Method ◽  
Group 13 ◽  
Patient Response ◽  
Percutaneous Nerve Evaluation ◽  
Late Treatment ◽  
Late Group

Introduction: Pelvic neuromodulation is an established method of treating voidingdysfunction. Little is known about the pathophysiology associated with voiding dysfunction. Reports have suggested that a delay in treating patients with sacral neuromodulation therapy can impact the success rate of this type oftreatment in voiding dysfunction. We examined patient response to pelvic neuromodulationwhen it was applied early versus late in the postdiagnosis of voidingdysfunction.Methods: We conducted a retrospective study of 42 patients (38 women and4 men) with voiding dysfunction who underwent surgery for implant with the Interstim (Medtronic, Minneapolis, Minn.). Prior to implantation, patients wererequired to pass a percutaneous nerve evaluation (PNE) over a 1-week period. Patients were observed for 20–48 months postimplantation. All patients recorded their voiding parameters at baseline, after screening and every 6 months thereafter. Twenty patients (in the early group) underwent implant surgery withthe neurostimulator 2–4 weeks post-PNE, and 22 patients (the late group)had the device implanted 6–24 months post-PNE owing to local logisticalcircumstances.Results: In the early group, 16 of 20 patients (80%) maintained a good response.In the late group, 13 of 22 (59%) patients showed a good response. Groupswere well matched in terms of age, duration of voiding dysfunction and incidenceof comorbidity.Conclusion: Patients who were delayed more than 6 months in receiving the neurostimulatorimplant showed a worse response than did patients who had thedevice implanted soon after PNE. This indicates the possibility of disease progression,which may limit the response to sacral neuromodulation.

Sign in / Sign up

Export Citation Format

Share Document